Skip to main content
. 2021 Sep 27;71(5):1093–1101. doi: 10.1007/s00262-021-03052-w

Table 2.

Response to treatment

Response of treatment
Total number of patients—68
Type of response—N (%)
 Complete response 1 (1.5%)
 Partial response 50 (73.5%)
 Stable disease 7 (10.3%)
 Progressive disease 2 (3.0%)
 Not evaluable 8 (11.7%)
Objective response rate (%) 75.0
Median duration of response (range)—months 3.3 (0.6–17.5)
Ongoing response at data cutoff—N (%) 15 (22.1%)